Introduction is expressed at all stages of cells undergoing positive selection, including DN and SP cells, but not in the maInterleukin-7 (IL-7) is a nonredundant cytokine for both jority of the DP cells that have failed positive selection T cell and B cell development (Peschon et al., 1994; and that will die by default (Gratiot-Deans et al., 1993 , Freeden-Jeffry et al., 1995 . IL-7 exerts its effect through Veis et al., 1993a; Akashi and Weissman, 1996) . the interaction of a high affinity receptor complex comBcl-2-deficient mice showed a gradual disappearance posed of the IL-7R␣ and the common cytokine receptor of T (and B) cells after the second postnatal week of life ␥ chain (␥ c) (Noguchi et al., 1993a; Kondo et al., 1994a) , (Veis et al., 1993b; Nakayama et al., 1994) . This suggests which is also an indispensable subunit for functional that Bcl-2 may protect thymocytes undergoing positive IL-2 (Takeshita et al., 1992) , IL-4 (Kondo et al., 1993;  selection (Linette et al., 1994; Tao et al., 1994; Akashi Russell et al., 1993) , IL-9 (Kimura et al., 1995) , and ILand Weissman, 1996) as well as peripheral T cells from 15 (Giri et al., 1994) receptors. Injection with neutralizing apoptotic stimuli such as levels of endogenous glucoantibodies to IL-7 or genetic ablation of either IL-7, ILcorticoid reached in the diurnal cycle (Weissman, 1994) 7R␣, or ␥ c inhibits both T and B cell development or stress. (Peschon et al., 1994; Bhatia et al., 1995; Cao et al., The enforced expression of Bcl-2 has been shown 1995; DiSanto et al., 1995; von Freeden-Jeffry et al., to maintain the viability of various cytokine-dependent 1995; Ohbo et al., 1996) . The molecular pathogenesis cells upon withdrawal of their dependent cytokines in of X-linked severe combined immunodeficiency (SCID) vitro (for reviews, see Vaux, 1993 and Yang and Korsin humans might be due primarily to ␥ c-mediated defects meyer, 1996) . In these situations, Bcl-2 itself does not in the IL-7/IL-7R system (Stephan et al., 1997) caused stimulate proliferation, but appears to enable cells to by mutation of the ␥ c gene (Noguchi et al., 1993b; Puck undergo intrinsically-determined differentiation through et al., 1993) .
maintenance of the viability of the cells in vitro (Fairbairn Thymic maturation from CD4 Ϫ CD8 Ϫ (DN) primitive et al., 1993) . Based on these data, we hypothesized progenitors involves rearrangement of TCR genes; exthat an important role of IL-7/IL-7R interactions in T cell pression of TCR with CD4 and CD8 coreceptors; positive development was to maintain cell survival. To test this selection of CD4 ϩ CD8 ϩ double positive (DP) cells that hypothesis, we introduced an E-bcl-2 transgene that corecognize self MHC class II molecules with CD4 and is selectively expressed in T lineage cells into IL-7R␣ Ϫ/Ϫ TCR, and self MHC class I with CD8 and TCR; negative mice. We show here that enforced expression of Bcl-2 in IL-7R␣ Ϫ/Ϫ mice results in a rescue of T lymphopoiesis. selection of autoimmune T cells; and commitment to selection had increased the expression of both molecules. Expression of both IL-7R␣ and Bcl-2 is maintained in differentiated thymic TCR hi SP cells ( Figure 1A ) as well as spleen TCR hi T cells. However, in IL-7R␣ Ϫ/Ϫ mice, the upregulation and maintenance of Bcl-2 is apparently impaired ( Figure 1B) ; the levels of endogenous Bcl-2 in thymocyte subsets such as DN, CD4 SP and CD8 SP cells, and those in spleen T cells in IL-7R␣ Ϫ/Ϫ mice were significantly lower than those in IL-7R␣ ϩ/Ϫ mice. These data suggest a possible link between IL-7/IL-7R interaction and endogenous Bcl-2 expression in T cells. To test this, we evaluated the effect of IL-7R engagement on endogenous Bcl-2 expression in T cells taken from IL-7-deficient (IL-7 Ϫ/Ϫ ) mice. As shown in Figure 1C , T cells isolated from the spleens of IL-7 Ϫ/Ϫ mice showed a reduction of Bcl-2 levels. However, when IL-7 Ϫ/Ϫ T cells were cultured with recombinant IL-7 for 18 hr, Bcl-2 levels were significantly increased. These data strongly suggest that IL-7R signaling might involve maintenance of Bcl-2 expression in developing thymocytes as well as in peripheral T cells.
IL-7R Signaling Is Required for Positive Selection
To clarify the possible role of IL-7R signaling in positive (Sudo et al., 1993) this experimental system, there was an increase in the numbers of SP progeny 3 days and 7 days after intrathymic injection; the SP (mainly CD4 SP) cells that appeared after 3 days were mainly the progeny of DP Results (c-Kit Ϫ ) precursors; and the SP cells (both CD4 and CD8 SP cells) that appeared after 6-7 days were progeny of IL-7R Engagement Induces High Level Expression of Bcl-2 during T Cell Maturation more immature DN to DP lo c-Kit ϩ IL-7R␣ ϩ precursors (Akashi et al., submitted). As shown in Figure 2A , the The first step of thymic positive selection includes an upregulation of their TCRs to medium-high levels (Guiadministration of A7R34 suppressed the differentiation of MHC Ϫ/Ϫ thymocytes along both the c-Kit ϩ and the dos et al., 1990; for reviews, see von Boehmer, 1994; Jameson et al., 1995; Guidos 1996) . This process begins c-Kit Ϫ pathways (Akashi and Weissman, 1996) to both CD4 and CD8 SP cells on days 3 and 7. at the DP stage (Shortman et al., 1991; Akashi and Weissman, 1996) . CD69 is an activation marker that is It was important to determine the role of cell division during positive selection in these experiments, because expressed on cells undergoing positive selection (Swat et al., 1993; Yamashita et al., 1993; Brandle et al., 1994) . the decrease of day 3 or day 7 progeny could result simply from the suppression of IL-7-dependent proliferThe positively selected cells downregulate either irrelevant CD4 or CD8 coreceptor (Guidos et al., 1990 ; Lucas ation by A7R34. Indeed, the decrease of day 7 progeny by A7R34 might result from the inhibition of IL-7-depenand Germain, 1996; von Boehmer, 1996) , and complete TCR upregulation. All cells undergoing positive selection dent expansion of the c-Kit ϩ IL-7R ϩ precursors (the c-Kit ϩ pathway; Akashi and Weissman, 1996) , since we express the IL-7R (Akashi et al., submitted) . Figure 1A shows IL-7R␣ and Bcl-2 expression in thyhave found that injection of A7R34 could inhibit the proliferation of c-Kit ϩ IL-7R ϩ precursors in normal mice mocytes in IL-7R␣ ϩ/Ϫ mice. Because virtually all thymocytes express ␥ c (Kondo et al., 1994b) and assessed the change in PKH26 intensity. A decline in the fluorescence signal from PKH26-labeled thymic population should be correlated with the number of cell divisions; each doubling of labeled cells corresponds to a 50% drop of the mean fluorescent signal as the dye present in the plasma membrane of the parent cell was divided between two daughter cells (Kraft et al., 1993) . To test whether a survival signal is involved, we provided by using E-bcl-2 MHC Ϫ/Ϫ mice as donors. We injected SP cells, but E-bcl-2 could antagonize this inhibitory effect of purified DP c-Kit
MHC Ϫ/Ϫ mice into MHC ϩ/ϩ thymi in the presence or absence of A7R34. After intrathymic injection, the positively selected DP cells immediately upregulated IL-7R␣ cells to complete the developmental program specified and TCR␤ (data not shown). This process does not inby positive selection, probably by maintaining their viavolve cell division (as described above). As shown in bility. Figures 2B and 3B , DP c-Kit Ϫ cells lacking Bcl-2 were blocked in their differentiation to SP (CD4) cells by A7R34, whereas the inhibitory effect of A7R34 was not Enforced Expression of Bcl-2 Restores T Cell Development in IL-7R␣ Ϫ/Ϫ Mice found on E-bcl-2 MHC Ϫ/Ϫ DP cells. Based on these data, we propose that the IL-7/IL-7R interaction is unIf IL-7 induces a survival response during thymic positive selection, Bcl-2 expression should rescue thymic cells likely to play a direct role in determining the differentiation of DP progenitors, but is important in permitting DP that had been largely absent in IL-7R␣ Ϫ/Ϫ mice (Peschon of thymic lymphocytes is restored in E-bcl-2 IL-7R␣ Ϫ/Ϫ mice to the profiles of normal thymus ( Figure 5A ). In the small number of cells in the IL-7R␣ Ϫ/Ϫ thymus, the ratio et al. , 1994) . To test this possibility, we introduced Ebcl-2 mice into the IL-7R␣ Ϫ/Ϫ strain by breeding and of CD4/CD8 SP thymocytes was widely variable. Expression of Bcl-2 in these thymi led to an almost normalized selection of E-bcl-2 IL-7R␣ Ϫ/Ϫ progeny. Results from the analysis of E-bcl-2 IL-7R␣ Ϫ/Ϫ mice are shown in CD4/CD8 SP ratio, confirming that E-bcl-2 could rescue both CD4 and CD8 lineage maturation ( Figures 5A  Figures 4 , 5, and 6. E-bcl-2 IL-7R␣ Ϫ/Ϫ mice produced a significant amount of peripheral T cells, approximately and 6). The small number of cells in the IL-7R␣ Ϫ/Ϫ thymus are also disproportionately skewed to TCR hi SP cells; 10-fold greater than those severely depleted in IL-7R␣ Ϫ/Ϫ mice ( Figure 4) ; the number of T cells from Ethe ratio of CD69 ϩ to CD69 Ϫ cells in TCR med-hi population in the IL-7R␣ Ϫ/Ϫ thymus was low, indicating that the bcl-2 IL-7R␣ Ϫ/Ϫ mice increased ‫-7ف‬fold in blood and ‫-11ف‬fold in spleen. The ratio of CD4 to CD8 SP cells in majority of these cells had not recently been positively selected ( Figure 5A ). On the other hand, the percentage these mice was almost equal to that in IL-7␣ ϩ/Ϫ mice ( Figure 4A ). We found no particular V␤ bias in the restoraof TCR med-hi CD69 ϩ thymocytes in E-bcl-2 IL-7R␣ . While c-Kit ϩ cells were absent from shown).
In the E-bcl-2 IL-7R␣ Ϫ/Ϫ thymus, there was a signifithe IL-7R␣ Ϫ/Ϫ thymus, these populations were also restored in the E-bcl-2 IL-7R␣
Ϫ/Ϫ thymus both in number cant increase in the number of thymocytes (‫-01ف‬fold) (Vaux et al., 1988;  the Kruskal-Wallis test. Fairbairn et al., 1993; Mazel et al., 1996) , although it is conceivable that Bcl-2 could be involved in preparing cells for mitosis. Bcl-2 could not substitute for signals and in the various stages of the c-Kit ϩ maturation pathgenerated during positive selection driven by TCR-MHC way (Akashi and Weissman, 1996) (Figure 6 ). These data interactions, because no SP maturation could be seen show significant restoration of thymocyte numbers and in lck pr -bcl-2 MHC Ϫ/Ϫ mice (Linette et al., 1994;  Tao et regeneration of all maturational stages of positive seal., 1994) or in the E-bcl-2 MHC Ϫ/Ϫ mice used in this lection. study (data not shown). T cells were also not rescued in lck pr -bcl-2 RAG1 Ϫ/Ϫ (Linette et al., 1994) or E-bcl-2 The Restored T Cells in E-bcl-2 IL-7R␣ Ϫ/Ϫ SCID mice (Strasser et al., 1994) . Enforced expression Mice Are Functional of Bcl-2 was reported to increase the number of CD3 med-hi
It was important to test whether the phenotypic restora-CD8 SP cells in the thymus (Linette et al., 1994 
; Tao et tion of T cells in the E-bcl-2 IL-7R␣
Ϫ/Ϫ mice signified al., 1994), although its effect on positive selection was functional maturation. Although IL-7R signaling was not not clear. required for T cell activation, IL-7R␣ Ϫ/Ϫ T cells have been In our study, the E-bcl-2 transgene could restore shown to be less responsive to alloantigen as well as to thymic development in IL-7R␣ Ϫ/Ϫ mice. Developing thyreceptor-independent stimuli (Maraskovsky et al., 1996) . mocytes in IL-7R␣ Ϫ/Ϫ mice expressed low levels of enAs shown in Figure 7 , IL-7R␣ Ϫ/Ϫ T cells were significantly dogenous Bcl-2. E-bcl-2 could substitute for the ILless responsive to either concanavalin A (ConA), anti-7R-mediated signals associated with positive selection CD3 plus CD28 stimulations, or allogeneic antigen as in a subset of progenitors (DP hi c-Kit Ϫ ) that did not unevaluated on a mixed lymphocyte reaction. In all of these dergo cell division in vivo during their maturation to CD4 assays, E-bcl-2 IL-7R␣ Ϫ/Ϫ T cells on a per cell basis (TCR hi ) SP cells. These results indicate that enforced could respond significantly better than the residual T expression of E-bcl-2 did not necessarily lead to posicells in IL-7R␣ Ϫ/Ϫ mice, and almost as well as T cells tive selection by modifying the cell cycle status of cells from IL-7R ϩ/Ϫ mice.
on the c-Kit Ϫ pathway (Linette et al., 1996; Mazel et al., 1996) . Accordingly, the reinforcement of survival by EDiscussion bcl-2 enables thymocytes to complete the differentiation program determined by positive selection and leads Our data show that enforced expression of Bcl-2 in T to significant increases in both CD69 ϩ and TCR lo-hi c-Kit ϩ lineage cells could restore T cell development considerthymocyte populations. ably in IL-7R␣
Ϫ/Ϫ mice. Accordingly, it is strongly sugThe survival signal induced by IL-7R might also play gested that the principal role of IL-7R signaling in developing thymocytes and mature T cells might be to a role in the proliferation of thymic precursors. We have reported that in normal mice, Bcl-2 expression is mainspleen (Young et al., 1997) . Accordingly, it appears that the particular signal transduction events responsible for tained through all stages of the positive selection process including cycling TCR lo-med c-Kit ϩ IL-7R␣ ϩ (DN . The c-Kit ligand, steel factor (Slf) is also a factor responsible for expansion of immature thyof IL-7R-mediated signals, though in vitro survival of IL-7R Ϫ/Ϫ mature T cells is impaired (Maraskovsky et al., mocytes (Rodewalt et al., 1995) , and the proliferation of c-Kit ϩ IL-7R␣ ϩ thymocytes is synergistically supported 1996). Hence, there remains a possibility that Bcl-2 may play a role in activating intracellular maturation proby IL-7 and Slf (Suda and Zlotnik, 1991; Akashi et al., submitted) . Accordingly, E-bcl-2 may maintain the regrams (Chen et al., 1997) as well as in maintaining cell survival during positive selection. Further studies of sponsiveness to Slf in TCR lo-med c-Kit ϩ populations in the IL-7R Ϫ/Ϫ thymus. However, the restoration of thymocyte downstream events associated with the expression of Bcl-2 are required to clarify this issue. numbers by E-bcl-2 was not complete. This may be at least partially because the E-bcl-2 transgene was
The possibility that other cytokines might have as a significant function the induced survival of their targets, not expressed before the developmental stages of TCR Ϫ c-Kit ϩ precursors ( Figure 5B ) that has not rearranged rather than directing differentiation in vivo, may be more general than the IL-7/IL-7R model described here. Else-TCR genes.
The malfunction of peripheral IL-7R␣ Ϫ/Ϫ T cells upon where, we present evidence that M-CSF delivers a survival signal for target monocytes in vivo, and that enstimulation has been characterized as reduced frequency of clonogenic expansion due to an increased forced expression of Bcl-2 in monocytes in op/op mice can rescue the differentiation of macrophage subsets rate of apoptotic cell death and a slower rate of proliferation (Maraskovsky et al., 1996) . The lack of IL-7R signaland significant reversal of their osteopetrosis (Lagasse and 
this issue of Cell]). Thus, certain ing results in impaired expression of endogenous Bcl-2 in IL-7R␣
Ϫ/Ϫ T cells, and might cause their augmented cytokines appear to enforce viability of their target cells in vivo. In the case of IL-7/IL-7R, proliferation and/or rate of apoptosis. The E-bcl-2 transgene protects IL-7R␣ Ϫ/Ϫ T cells from apoptosis probably before and after maturation of T cells that result from internal gene programs or other external stimuli (including other cytokine activation, and normalizes their in vitro response to either antigen-specific or antigen-independent stimuli. receptor/cognate cytokine interactions) could occur on condition that the cells do not die. The hypoplasia of the lymphoid system in IL-7R␣ Ϫ/Ϫ mice is probably not simply due to the disruption of IL-7/IL-7R interaction, because IL-7R␣ is also used as
Experimental Procedures
a receptor for other ligands, e.g., for receptor complexes of thymic stromal cell-derived lymphopoietin (Friend et Mice C57BL/6-Ly5.1 mice were bred and maintained in the central animal Ray et al., 1996) . We found a similar impairment , 1994) . We have observed a null mutation in the A␤ b gene (MHC class II-deficient mice). E-T cell but not B cell restoration by introducing either the bcl-2-25 mice, in which the human bcl-2 transgene is expressed mainly in T-lineage cells (Strasser et al., 1991) , were backcrossed E-bcl-2 or the H2K-bcl-2 transgene into the ␥c Ϫ/Ϫ mice, with C57BL/Ka (H-2 b ) (Ly5.2) for three generations. The MHC Ϫ/Ϫ Ein the latter of which the bcl-2 transgene was expressed bcl-2 mice were generated by crossing with the E-bcl-2-25 mice in virtually all hematopoietic cells (Kondo et al., 1997) . not to be able to rescue ␥/␦ T and B cells, although the 53-6.7 (anti-CD8) and 6B2 (anti-B220) and F23.1 (anti-V␤8.2). Neu-E-bcl-2 was expressed in a considerable fraction of tralizing anti-IL-7R (A7R34) antibodies are kind gifts from S. Nishithe IgM Ϫ B220 ϩ CD43 ϩ pro-B cell population in bone kawa (Kyoto University). Mouse and hamster antibodies were purimarrow (data not shown). Engagement of the IL-7R comfied by protein A affinity chromatography, and rat antibodies were plex is reported to be critical for the development of ␥/␦ purified by protein G affinity chromatography. These antibodies are T cells (Appasamy et al., 1993; He and Malek, 1996;  directly conjugated with phycoerythrin (PE) (Cyanotech Corporation, Kailua-Kona, Hawaii), fluorescein-5isothiocyanate (FITC) (Molecular Maki et al., 1996) . The IL-7R complex also plays a crucial (Guidos et al., 1990) . Thymocytes from MHC Ϫ/Ϫ mice (Ly5.2) were sorted into 10 l of saline and injected into a thymic lobe of anesthetized, unirradiated 3-to 5-week-old C57BL/6-Ly5.1 mouse References with either intraperitoneal injection of 1 mg of A7R34 or equal volumes of PBS. The same doses of A7R34 or PBS were intraperitoneAdkins, B., Mueller, C., Okada, C.Y., Reichert, R.A., Weissman, I.L., ally administered on days 2 and 4. Individual thymic lobes were and Spangrude, G.J. (1987) . Early events in T-cell maturation. Annu. harvested and stained with PE-53-6.7, APC-GK1.5, and FITC-Ly5.2.
Rev. Immunol. 5, 325-365. The donor cells were the PI-negative, FITC-positive population. We Akashi, K., and . The c-Kit ϩ maturation pathway directly analyzed one-fourth of the cells from each lobe without in mouse thymic T cell development: lineage and selection. Immunity enriching for donor-derived cells by immunomagnetic beads (Gui-5, 147-161. dos et al., 1990; Akashi and Weissman, 1996) , to avoid the loss of Appasamy, P.M., Kenniston, T.W., Jr., Weng, Y., Holt, E.C., Kost, donor-derived cells. All events of donor-derived cells were collected J., and Chambers, W.H. (1993) . Interleukin-7-induced expression of by setting electronic gates. specific T cell receptor-␥ variable region genes in murine fetal liver cultures. J. Exp. Med 178, 2201-2206.
PKH26 Labeling of Thymocytes
Bhatia, S.K., Tygrett, L.T., Grabstein, K.H., and Waldschmidt, T.J. Freshly isolated thymocytes were labeled with PKH26 (PKH26 red (1995) . The effect of in vivo IL-7 deprivation on T cell maturation. J. fluorescent general cell linker kit, Sigma Immuno Chemicals), which Exp. Med. 181, 1399 -1409 . is a stable, fluorescent dye that incorporates into the cell membrane.
Brandle, D., Muller, S., Muller, C., Hengartner, H., and Pircher, H. PKH26 has an excitation peak of 551 nm and an emission peak of (1994) . Regulation of RAG-1 and CD69 expression in the thymus 567 nm. The PE channel on the FACS was used to measure PKH26 during positive and negative selection. Eur. J. Immunol. 24, 145-151. levels. Cells were stained with PKH26 according to the supplier's Cao, X., Shores, E.W., Hu-Li, J., Anver, M.R., Kelsall, B.L., Russell, recommendation with slight modification. Briefly, cells are resus-S.M., Drage, J., Noguchi, M., Grinberg, A., Bloom, E.T., Paul, W.E., pended in Diluent C (Sigma Immuno Chemicals) at 2 ϫ 10 6 cells/ml Katz, S.I., Love, P.E., and Leonard, W.J. (1995) . Defective lymphoid in polypropylene tubes and an equal volume of 2 M PKH26 in development in mice lacking expression of the common cytokine Diluent C was added to the cells. Cells were incubated in the resulreceptor ␥ chain. Immunity 2, 223-238. tant 1 M PKH26 with continuous mixing for 3 min. The reaction was stopped by adding an equal volume of FCS. Cells were washed Chen, D.F., Schneider, G.E., Martinou, J.-C., and Tonegawa, S. three times with HBSS containing 10% FCS. Cells were resuspended (1997). Bcl-2 promotes regeneration of severed axons in mammalian in RPMI (without phenol red) supplemented with 10% FCS, and CNS. Nature 385, 434-439. incubated at 37ЊC for 1-2 hr. The cells were washed twice with Corcoran, A.E., Smart, F.M., Cowling, R.J. Crompton, T., Owen, M.J., HBSS containing 10% FCS; stained with FITC-53-6.7, APC-GK1.5, and Venkitaraman, A.R. (1996) . The interleukin-7 receptor ␣ chain and PI (1 mg/ml); and purified with the FACS. We noticed some transmits distinct signals for proliferation and differentiation during nonspecific decrease in the mean PKH26 signals after intrathymic B lymphopoiesis. EMBO J. 15, 1924 EMBO J. 15, -1932 . injection, probably due to the release of PKH26 that may have Cory, S. (1995) . Regulation of lymphocyte survival by the BCL-2 attached to the cell membrane in a nonspecific manner. A control gene family. Annu. Rev. Immunol. 13, 513-543. value for PKH26 was determined by measuring the first peak of DiSanto, J.P., Muller, W., Guy-Grand, D., Fischer, A., and Rajewsky, PKH26 signal from the donor-derived (injected) DP fraction (in which K. (1995) . Lymphoid development in mice with a targeted deletion most cells could not divide). Usually, the first peak of PKH26 became of the interleukin-2 receptor ␥ chain. Proc. Natl. Acad. Sci. USA. 92, stable within 48 hrs after intrathymic injection. The PMT voltage 377-381. on each fluorescence channel was set on an automatic computed calibration system on the FACS/DESK program using the same Fairbairn, L.J., Cowling, G.J., Reipert, B.M., and Dexter, T.M. (1993) . Suppression of apoptosis allows differentiation and development control beads.
